Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis. It is sometimes used as a drug of last resort for primary amoebic meningoencephalitis. For certain infections it…
History & Applications
Explore the main themes, entities and connections around Amphotericin B. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
amphotericin drug fungal effects may side also used infections toxicity lipid deoxycholate formulations liposomal cell membrane serious complex kidney low
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Amphotericin B | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Amphotericin B | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Amphotericin B | ATC code | A01AB04 (WHO) A07AA07 (WHO), G01AA03 (WHO), J02AA01 (WHO) | 1.00 | infobox |
| Amphotericin B | Bioavailability | 100% (IV) low (oral) | 1.00 | infobox |
| Amphotericin B | CAS Number | 1397-89-3 Y | 1.00 | infobox |
| Amphotericin B | ChEBI | CHEBI:2682 Y | 1.00 | infobox |
| Amphotericin B | ChEMBL | ChEMBL267345 Y | 1.00 | infobox |
| Amphotericin B | ChemSpider | 10237579 Y | 1.00 | infobox |
| Amphotericin B | CompTox Dashboard (EPA) | DTXSID9022601 | 1.00 | infobox |
| Amphotericin B | DrugBank | DB00681 Y | 1.00 | infobox |
| Amphotericin B | ECHA InfoCard | 100.014.311 | 1.00 | infobox |
| Amphotericin B | Elimination half-life | Initial phase: 24 hours | 1.00 | infobox |
| Amphotericin B | Elimination half-life | Second phase: approximately 15 days | 1.00 | infobox |
| Amphotericin B | Excretion | 40% found in urine after single cumulated over several days | 1.00 | infobox |
| Amphotericin B | Excretion | Biliary excretion is also important | 1.00 | infobox |
| Amphotericin B | Formula | C47H73NO17 | 1.00 | infobox |
| Amphotericin B | KEGG | D00203 Y | 1.00 | infobox |
| Amphotericin B | Legal status | US: ℞-only | 1.00 | infobox |
| Amphotericin B | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Amphotericin B | License data | US DailyMed: Amphotericin_B | 1.00 | infobox |
| Amphotericin B | MedlinePlus | a682643 | 1.00 | infobox |
| Amphotericin B | Melting point | 170 °C (338 °F) | 1.00 | infobox |
| Amphotericin B | Metabolism | kidney | 1.00 | infobox |
| Amphotericin B | Molar mass | 924.091 g·mol−1 | 1.00 | infobox |
| Amphotericin B | NIAID ChemDB | 000096 | 1.00 | infobox |
| Amphotericin B | Pregnancy category | AU: B2 | 1.00 | infobox |
| Amphotericin B | PubChem CID | 5280965 | 1.00 | infobox |
| Amphotericin B | Routes of administration | Intravenous infusion | 1.00 | infobox |
| Amphotericin B | Trade names | Fungizone, Mysteclin-F, AmBisome and other | 1.00 | infobox |
| Amphotericin B | UNII | 7XU7A7DROE | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.